Chronic Lung Allograft Dysfunction (CLAD): Clinical Trials

1 trial for Chronic Lung Allograft Dysfunction (CLAD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Chronic Lung Allograft Dysfunction (CLAD): new trials by email Literature Review of Chronic Lung Allograft Dysfunction (CLAD) trials Research Report on Chronic Lung Allograft Dysfunction (CLAD)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction
Bone-marrow derived MSCs, Placebo - Chronic Lung Allograft Dysfunction (CLAD)
Phase 2CompletedThe University of Queensland642017-04-212023-12-06

Sponsors

The University of Queensland (1)

Countries

Australia (1)

Top investigators

Daniel Chambers, MBBS MD (1)